Catalyst Wire Dossier Catalyst Wire Dossier

Gimistotug

BGB-A445 · BeiGene
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gimistotug, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer [Phase 2]

See pricing